pentobarbital will minimize the level or outcome of buprenorphine subdermal implant by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Keep track of Closely. Keep track of clients already on buprenorphine subdermal implant who require recently-initiated remedy with CYP3A4 inducer for indicators and signs and symptoms of withdr